INFINITY PHARMACEUTICALS INC (INFI)
US45665G3039 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.95M | -44.37M | -45.26M | -40.50M | -47.10M | |||
| Depreciation Amortization | 428.00K | 458.00K | 480.00K | 500.00K | 200.00K | |||
| Change In Working Capital | -1.56M | -1.04M | 2.21M | 1.40M | 1.40M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 3.19M | 2.52M | 1.95M | 2.90M | 3.90M | |||
| OPERATING CASH FLOW | -38.88M | -42.43M | -40.62M | -35.70M | -41.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -17.00K | -11.00K | 0.00 | -2.30M | |||
| Other Investing Activity | 10.73M | -38.00K | 5.50M | 14.70M | -9.90M | |||
| INVESTING CASH FLOW | 10.73M | -55.00K | 5.49M | 14.60M | -12.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 73.00K | 87.11M | 7.90M | 100.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | 19.60M | 27.60M | |||
| FINANCING CASH FLOW | N/A | 73.00K | 87.11M | 27.40M | 27.70M | |||
| CHANGE IN CASH | -28.09M | -42.41M | 51.98M | 6.30M | -26.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.88M | -42.43M | -40.62M | -35.70M | -41.50M | |||
| Capital Expenditure | 0.00 | -17.00K | -11.00K | 0.00 | -2.30M | |||
| FREE CASH FLOW | -38.88M | -42.45M | -40.63M | -35.70M | -43.80M | |||
All data in USD